These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1380243)

  • 1. Molecular mode of action of cyclosporin and FK506 in human thymocytes.
    Reem GH
    J Autoimmun; 1992 Apr; 5 Suppl A():159-65. PubMed ID: 1380243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the properties of the CsA analogs monoacetyl CyC (o-acetyl-threonine2 cyclosporin) and methyl-alanyl CsA (N-methyl-L-alanyl6 cyclosporin); monoacetyl cyclosporin is immunosuppressive without binding to cyclophilin.
    el Rouby S; Shi Y; Reem GH
    Clin Exp Immunol; 1992 Jul; 89(1):136-42. PubMed ID: 1628422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin.
    Teutsch M; Higer M; Wang D; Wortis HW
    Int Immunol; 1995 Mar; 7(3):381-92. PubMed ID: 7540861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level.
    Andersson J; Nagy S; Groth CG; Andersson U
    Immunology; 1992 Jan; 75(1):136-42. PubMed ID: 1371491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T cell responses to human and porcine endothelial cells are highly sensitive to cyclosporin A and FK506 in vitro.
    Batten P; McCormack AM; Page CS; Yacoub MH; Rose ML
    Transplantation; 1999 Nov; 68(10):1552-60. PubMed ID: 10589954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SRC-related proto-oncogenes and transcription factors in primary human T cells: modulation by cyclosporin A and FK506.
    Granelli-Piperno A
    J Autoimmun; 1992 Apr; 5 Suppl A():145-58. PubMed ID: 1380242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine A and FK506 induce osteoclast apoptosis in mouse bone marrow cell cultures.
    Igarashi K; Hirotani H; Woo JT; Stern PH
    Bone; 2004 Jul; 35(1):47-56. PubMed ID: 15207740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A and FK506 reduce interleukin-5 mRNA abundance by inhibiting gene transcription.
    Rolfe FG; Valentine JE; Sewell WA
    Am J Respir Cell Mol Biol; 1997 Aug; 17(2):243-50. PubMed ID: 9271313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunosuppressive drugs cyclosporin A and FK506 inhibit calcineurin phosphatase activity and gene transcription mediated through the cAMP-responsive element in a nonimmune cell line.
    Schwaninger M; Blume R; Oetjen E; Knepel W
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):541-5. PubMed ID: 7509460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cyclosporin A/FK506 resistant, lymphokine-induced T-cell activation by phenothiazine derivatives.
    Schleuning M; Brumme V; Wilmanns W
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jul; 350(1):100-3. PubMed ID: 7523957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A and FK-506 both affect DNA binding of regulatory nuclear proteins to the human interleukin-2 promoter.
    Baumann G; Geisse S; Sullivan M
    New Biol; 1991 Mar; 3(3):270-8. PubMed ID: 1715185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
    Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
    J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin a inhibits calcineurin/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells.
    Eckstein LA; Van Quill KR; Bui SK; Uusitalo MS; O'Brien JM
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):782-90. PubMed ID: 15728531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.
    Sawada S; Suzuki G; Kawase Y; Takaku F
    J Immunol; 1987 Sep; 139(6):1797-803. PubMed ID: 2442255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells.
    Nishiyama S; Manabe N; Kubota Y; Ohnishi H; Kitanaka A; Tokuda M; Taminato T; Ishida T; Takahara J; Tanaka T
    Int Immunopharmacol; 2005 Apr; 5(4):699-710. PubMed ID: 15710339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
    Hess DA; Bird IA; Almawi WY; Rieder MJ
    J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of activation-induced changes in the structure of the T cell interleukin-7 receptor by cyclosporin A and FK506.
    Foxwell BM; Willcocks JL; Taylor-Fishwick DA; Kulig K; Ryffel B; Londei M
    Eur J Immunol; 1993 Jan; 23(1):85-9. PubMed ID: 7678231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter.
    Granelli-Piperno A; Nolan P; Inaba K; Steinman RM
    J Exp Med; 1990 Dec; 172(6):1869-72. PubMed ID: 1701825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cyclosporin A and FK506 on Fc epsilon receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12.
    Kaye RE; Fruman DA; Bierer BE; Albers MW; Zydowsky LD; Ho SI; Jin YJ; Castells MC; Schreiber SL; Walsh CT
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8542-6. PubMed ID: 1382293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of action of cyclosporin A and FK506.
    Ho S; Clipstone N; Timmermann L; Northrop J; Graef I; Fiorentino D; Nourse J; Crabtree GR
    Clin Immunol Immunopathol; 1996 Sep; 80(3 Pt 2):S40-5. PubMed ID: 8811062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.